Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

WILLIAM'S HEMATOLOGY > 36 Aplastic Anemia: Acquired and Inherited > Flashcards

36 Aplastic Anemia: Acquired and Inherited Flashcards

1
Q

The diagnosis of Aplastic Anemia usually requires the presence of pancytopenia defined as:

Neutrophil count:
Platelet count:
Hemoglobin:
Absolute Reticulocyte count:

accompanied by a hypocellular marrow without abnormal or malignant cells or fibrosis

A

Neutrophil count: fewer than 1.5 × 109/L
Platelet count: fewer than 50 × 109/L
Hemoglobin: less than 100 g/L
Absolute Reticulocyte count: fewer than 40 × 109/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Degree of Severity of Acquired Aplastic Anemia

Moderately severe:
Severe:
Very severe:

A

Moderately severe: Hgb <100 g/L ARC <40.0 × 109/L NC <1.5 × 109/L PC <50.0 × 109/L

Severe: Hgb <90 g/L ARC <30.0 × 109/L NC <0.5 × 109/L PC <30.0 × 109/L

Very severe: Hgb <80 g/L ARC <20.0 × 109/L NC <0.2 × 109/L PC <20.0 × 109/L

Moderately severe: At the time of diagnosis at least 2 of 3 blood counts should meet these criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The highest frequency of aplastic anemia occurs in persons between the ages of_______years; a second peak occurs between the ages of ________years.

A

15 and 25 years

65 and 69 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The male-to-female incidence ratio of aplastic anemia in most studies is approximately

A

One

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Toxins that cause AA

A
  • Benzene
  • Chlorinated hydrocarbons
  • Organophosphates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Viruses that cause AA

A
  • Epstein-Barr virus
  • Non-A, -B, -C, -D, -E, or -G hepatitis virus
  • HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Inherited Causes of AA

A
  • Fanconi anemia
  • Dyskeratosis congenita
  • Shwachman-Diamond syndrome
  • Other rare syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The final common pathway to the clinical disease is

A

A decrease in blood cell formation in the marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Reduced hematopoiesis in most cases of aplastic anemia results from

A

Cytotoxic T-cell–mediated immune suppression of very early CD34+ hematopoietic multipotential progenitor or stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A relationship between acquired aplastic anemia and hereditary aplastic anemia (FA or dyskeratosis congenita) has been suggested because of the defects in _______________________

A

Telomerase and telomere repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The most notorious drug documented to cause aplastic anemia

A

Chloramphenicol

The occurrence of aplastic anemia appears to be idiosyncratic, perhaps related to an inherited sensitivity to the nitroso-containing toxic intermediates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-malarial with evidence that it cause AA

A

Quinacrine (Atabrine)

The aplasia occurred during administration of the offending agent and was preceded by a characteristic rash in nearly half the cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes AA because there is delayed oxidation and clearance of a related compound, acetanilide

A

Phenylbutazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A histamine H2-receptor antagonist, is occasionally implicated in the onset of cytopenias and aplastic anemia, perhaps owing to a direct effect on early hematopoietic progenitor cells

A

Cimetidine

There is drug interactions or synergy with: carmustine and chloramphenicol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs Associated with Aplastic Anemia - High Risk

A

Antineoplastic drugs:
Alkylating agent
Antimetabolite
Cytotoxic antibiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Was the first chemical linked to aplastic anemia, based on studies in factory workers before the 20th century

A

Benzene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

An uncommon connective tissue disorder with painful swelling and induration of the skin and subcutaneous tissue, has been associated with aplastic anemia

Has been largely unresponsive to therapy

A

Eosinophilic fasciitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Total-body exposure to radiation between _______Gy leads to gastrointestinal symptoms and depression of leukocyte counts, but most patients recover.

A

1 and 2.5 Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Although unusual, severe marrow aplasia can follow use of the alkylating agent,________, and may persist indefinitely.

A

Busulfan

Marrow aplasia may develop in patients 2–5 years after discontinuation of alkylating agent therapy.

These cases often evolve into hypoplastic myelodysplastic syndromes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A rare exception to the negligible pathogenetic role of hematopoietic growth factors in the etiology of aplastic anemia is the homozygous or mixed heterozygous mutation of the TPO receptor gene, MPL, which can cause

A

Amegakaryocytic thrombocytopenia

Evolves later into aplastic anemia

Eltrombopag, a TPO receptor agonist, can stimulate mono- or, in some patients, bilineage or trilineage recovery of blood counts that may be sustained off therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TRUE OR FALSE

Lymphadenopathy and splenomegaly are not features of aplastic anemia; such findings suggest an alternative diagnosis such as a clonal myeloid or lymphoid disease.

A

TRUE

Lymphadenopathy and splenomegaly are not features of aplastic anemia; such findings suggest an alternative diagnosis such as a clonal myeloid or lymphoid disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

TRUE OR FALSE

Significant qualitative changes of red cell, leukocyte, or platelet morphology on the blood film are features of classical acquired aplastic anemia.

A

FALSE

Significant qualitative changes of red cell, leukocyte, or platelet morphology on the blood film are not features of classical acquired aplastic anemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TRUE OR FALSE

The plasma contains high levels of hematopoietic growth factors, including EPO, TPO, and myeloid colony-stimulating factors.

A

TRUE

The plasma contains high levels of hematopoietic growth factors, including EPO, TPO, and myeloid colony-stimulating factors.

Other findings:
* Macrocytes may be present in the blood film and the mean cell volume increased.
* Platelets function normally.
* Occasionally only one cell line is depressed initially

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

TRUE OR FALSE

Plasma iron values are usually high, and Fe clearance is prolonged, with decreased incorporation into red cells.

A

TRUE

Plasma iron values are usually high, and Fe clearance is prolonged, with decreased incorporation into red cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Marrow Findings in Aplastic anemia

A

Numerous spicules with empty, fat-filled spaces, and relatively few hematopoietic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Refers to spicules that are cellular or even hypercellular

A

“hot spots”

These focal areas of residual hematopoiesis do not appear to be of prognostic significance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Cytogenetic analysis in aplastic anemia is

A

Normal

Clonal cytogenetic abnormalities in otherwise apparent aplastic anemia is indicative of an underlying hypoplastic clonal myeloid disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Imaging that can be used to distinguish between marrow fat and hematopoietic cells

A

Magnetic resonance imaging

Magnetic resonance imaging studies of bone may be useful in differentiating severe aplastic anemia from clonal myeloid syndromes. The former gives a fatty signal and the latter a diffuse cellular pattern.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

A reticulocyte percentage of less than ______% is strongly indicative of aplastic erythropoiesis and, when coupled with leukopenia and thrombocytopenia, points to aplastic anemia.

A

0.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

As many as_____ of patients with otherwise typical aplastic anemia have evidence of glycosylphosphatidylinositol molecule defects and diminished phosphatidylinositol-anchored protein on leukocytes and red cells as judged by flow cytometry, analogous to that seen in PNH.

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

As many as____% of patients with aplastic anemia have a five-year probability of myelodysplasia developing.

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Mutations that are increased in prevelance with patient age

A

ASXL1 and DNMT3A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Mutations that were of similar frequency in all age groups

A

BCOR, BCORL1, and PIGA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Three principal options: for treatment in AA

A

(1) syngeneic or allogeneic hematopoietic cell transplantation
(2) combination immunosuppressive therapy with ATG and cyclosporine, and
(3) eltrombopag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

TRUE OR FALSE

In general, transplantation is the preferred treatment for children and most otherwise healthy younger adults.

A

TRUE

In general, transplantation is the preferred treatment for children and most otherwise healthy younger adults.

36
Q

The preferred stem cell source

A

A histocompatible sibling matched at the HLA-A, -B, -C, and -DR loci

An allele-level HLA-matched unrelated donor can be used in younger patients

37
Q

TRUE OR FALSE

Red cell and platelet transfusions be used sparingly in potential transplant recipients to minimize sensitization to histocompatibility antigen

A

TRUE

Red cell and platelet transfusions be used sparingly in potential transplant recipients to minimize sensitization to histocompatibility antigen

38
Q

Packed red cells to alleviate symptoms of anemia usually are indicated at hemoglobin values:

A

Below 80 g/L

39
Q

TRUE OR FALSE

It is important to transfuse patients with red cells (or platelets) from family members if transplantation within the family is possible

A

FALSE

It is important not to transfuse patients with red cells (or platelets) from family members if transplantation within the family is remotely possible

Because this approach may sensitize patients to minor histocompatibility antigens, increasing the risk of graft rejection after hematopoietic cell transplantation.

40
Q

Preferred platelet unit for previously pregnant or transfused patients who are already allosensitized or who become so after treatment with leukoreduced platelets

A

Single-donor HLA-matched apheresis-harvested platelets

41
Q

The major curative approach in AA

A

Hematopoietic Cell Transplantation

The results of transplantation are best in patients younger than age 20 years (80%–90% long-term survival) but decrease every decade of increasing age thereafter.

Optimal with HLA-matched sibling transplantation.

42
Q

TRUE OR FALSE

Marrow stem cells perform better than blood stem cells when used as a source for patients with aplastic anemia, although this is under continued study.

A

TRUE

Marrow stem cells perform better than blood stem cells when used as a source for patients with aplastic anemia, although this is under continued study.

43
Q

In patients older than age 40 years, survival in matched-sibling transplant is reduced to approximately________%.

A

50%

44
Q

Regimen that appear to improve outcome by decreasing the frequency of chronic graft-versus-host disease, which could make it useful in treating older patients.

A

Alemtuzumab-containing regimens

45
Q

If there is an HLA mismatch at one or more loci, especially _____or ____, the outcome is compromised,and immunosuppression with combined therapy may be preferred initially

A

HLA-A or -DRB1

46
Q

Act principally by reducing cytotoxic T cells

Release hematopoietic growth factors from T cells

A

Antilymphocyte and Antithymocyte Globulin

47
Q

TRUE OR FALSE

Rabit ATG is superior to equine and, if available, is recommended as the first line of therapy

A

FALSE

Equine ATG is superior to rabbit and, if available, is recommended as the first line of therapy

48
Q

TRUE OR FALSE

ATG treatment may accelerate platelet destruction, reduce the absolute neutrophil count, and cause a positive direct antiglobulin (Coombs’) test.

A

TRUE

ATG treatment may accelerate platelet destruction, reduce the absolute neutrophil count, and cause a positive direct antiglobulin (Coombs’) test.

49
Q

Characterized by spiking fevers, skin rashes, and arthralgia, commonly occurs 7–10 days from the first dose

A

Serum sickness

50
Q

Management of Serum sickness

A
  • Glucocorticoid (eg, prednisone 1 mg/kg) from day one of ATG treatment and for two weeks thereafter
  • Fever, rigors, rash, hypotention, and hypoxia can be minimized by administration of acetaminophen and diphenhydramine before each dose of ATG.
  • Supplementation with intravenous hydration for hypotension and oxygen administration for hypoxia.
  • In cases of severe reactions, the administration of ATG can be slowed or temporarily discontinued until improvement occurs, and then reinstituted at a slower rate of infusion if necessary.
51
Q

Approximately _______of patients no longer require transfusion support after treatment with ATG alone.

A

One-third

52
Q

A cyclic polypeptide that inhibits IL-2 production by T lymphocytes and prevents expansion of cytotoxic T cells in response to IL-2

A

Cyclosporine

53
Q

Initial dose of Cyclosporine

A

10–12 mg/kg per day for at least 6 months and with downward dose modification after six months for as long as 12 months.

Responses usually are seen by three months and may range from achieving transfusion independence to complete remission

54
Q

Trough blood levels of Cyclosporine

A

200–400 ng/mL

55
Q

A TPO receptor agonist used to stimulate platelet production in patients with immune thrombocytopenia

May expand stem cell numbers and promote DNA repair

A

Eltrombopag

Multilineage hematopoietic response occurred, leading to restoration of granulopoiesis, erythropoiesis, and megakaryocytopoiesis with a subsequent increase in neutrophil, erythrocyte, and platelet counts, sometimes to normal levels

MPL receptors are present on hematopoietic stem cells

A higher dose of eltrombopag (150 mg/day) and longer treatment (at least 24 weeks) increases the likelihood of response

56
Q

Combination Immunotherapy

A
  • ATG (40 mg/kg per day) for 4 day
  • Cyclosporine (6 mg/kg per day in divided doses every 12 hours) for 6 months
  • Methylprednisolone (1 mg/kg per day) for 2 weeks
  • Eltrombopag is given at 150 mg from day 1 for 6 months
57
Q

TRUE OR FALSE

G-CSF added to the combined immunosuppressive therapy does not increase response rate or survival.

A

TRUE

G-CSF added to the combined immunosuppressive therapy does not increase response rate or survival.

58
Q

A monoclonal anti-CD52 antibody that targets that antigen on T lymphocytes, has been an effective immunosuppressive agent in both relapsed and refractory patients

A

Alemtuzumab

59
Q

An alternative thrombopoietin receptor agonist that is a larger molecule than eltrombopag and requires parenteral administration

It binds to the thrombopoietin receptor site, cMPL

A

Romiplostim

60
Q

Alemtuzumab produces profound and persistent___________.

A

Lymphopenia

61
Q

Stimulate the production of EPO, and their metabolites stimulate erythropoiesis when added to marrow cultures in vitro.

May be useful in the treatment of aplastic anemia syndromes resulting from shortened telomeres.

A

Androgens

62
Q

Therapy with myeloid growth factors is probably best reserved for

A

Episodes of severe infection

As a preventive measure before dental work or other procedures that would compromise mucosal barriers in patients who have not responded to hematopoietic cell transplant or immunotherapy

  • Generally, prophylactic use of growth factors is not warranted.
63
Q

TRUE OR FALSE

Prophylactic use of growth factors is warranted.

A

FALSE

Prophylactic use of growth factors is not warranted.

64
Q

The most important prognostic feature

A

Absolute neutrophil count

65
Q

Hematopoietic cell transplantation is curative for approximately:

Patients younger than 20 years of age:
Between the ages of 20 and 40 years:
Older than age 40 years:

A

Patients younger than 20 years of age: 80%–90%
Between the ages of 20 and 40 years: 70%
Older than age 40 years 50%

66
Q

The best outcomes occur in patients who have:

A
  • Allele-based HLA-matched sibling
  • Have not been exposed to immunosuppressive therapy before transplantation
  • Have not been exposed and sensitized to blood cell products
  • Have had a marrow rather than a blood stem cell donor product, and
  • Have not been subjected to high-dose radiation in the conditioning regimen for transplantation
67
Q

Predictive of a better response to therapy

A
  • Higher initial absolute reticulocyte and lymphocyte counts
  • High proportion of Treg B cells
68
Q

AD Rare Inherited Syndromes Associated with Aplastic Anemia

A
  • Ataxia-pancytopenia (myelocerebellar disorder)
  • WT syndrome

The rest autosomal recessive

69
Q

The most common form of constitutional aplastic anemia

The great majority of patients have mutations of FANCA, FANCC, or FANCG

A

Fanconi anemia (FA)

70
Q

First step in understanding the genetic basis of FA

A

Diepoxybutane test

In this test, diepoxybutane results in chromosome fragmentation in the cells of patients with FA.

71
Q

Hereditary cause of AA: pancreatic insufficiency, steatorrhea

A

Schwaman Diamond Syndrome

72
Q

Approximately 5% of patients with FA exhibit the _____________ phenotype

A

VACTERL with hydrocephalus (VACTERL-H)

This requires having 3 of 8 features, including vertebral anomalies, anal atresia, congenital heart disease, tracheoesophageal fistula, esophageal atresia, renal abnormalities, limb abnormalities, and hydrocephalus

73
Q

Hereditary cause of AA: nail dystrophy, mucosal leukoplakia

A predisposition to malignant transformation

The disease is a reflection of telomere complex dysfunction and results from defective telomerase activity resulting from mutations in the telomerase-related genes

A

Dyskeratosis congenita

74
Q

Responsible for the X-linked recessive form of Dyskeratosis congenita

A

DKC1 gene

DKC1 encodes dyskerin, which is a conserved multifunctional protein component of the telomerase complex

75
Q

Homozygous recessive mutations in the TERT gene produce a severe variant of dyskeratosis, referred to as the

A

Hoyeraal-Hreidarsson syndrome

76
Q

Used to confirm Dyskeratosis congenita

A

Genetic analysis for telomerase complex gene mutations

77
Q

TRUE OR FALSE

In Dyskeratosis congenita, transplantation might improve the cytopenias, but not the abnormalities of other organs or the frequency of secondary nonhematopoietic cancer.

A

TRUE

In Dyskeratosis congenita, transplantation might improve the cytopenias, but not the abnormalities of other organs or the frequency of secondary nonhematopoietic cancer.

The incidence of squamous cell carcinoma of mucosal sites is increased, and the squamous cell carcinoma often originates in sites of leukoplakia in the skin, gastrointestinal, or genitourinary tracts.

78
Q

Manifests as exocrine pancreatic insufficiency with secondary steatorrhea, blood cell deficiencies, and skeletal abnormalities

Results from mutations in the SBDS gene on chromosome 7q11, which induces accelerated cellular apoptosis via the FAS pathway

A

Shwachman-Diamond syndrome

79
Q

Shwachman-Diamond syndrome

Pancreatic insufficiency can be established by

A

Low serum trypsinogen

in patients younger than 3 years of age

80
Q

Cytogenetic abnormalities involving chromosomes _________ have been described in marrow cells of patients with Shwachman-Diamond syndrome

A

Chromosomes 7 and 20

Have a significant risk of progression to a myelodysplastic syndrome or AML

81
Q

Results from mutations in the TPO receptor gene, MPL

A

Congenital (hereditary) amegakaryocytic thrombocytopenia (CAMT)

  • CAMT I with mutations leading to complete loss-of-function of the TPO receptor, resulting in more severe thrombocytopenia and a rapid progression to pancytopenia (aplastic anemia)
  • CAMT II, resulting from a variety of missense mutations, in which affected children have an increase in platelet count above 50 × 109/L with time and much slower progression to and sometimes less severe pancytopenia
82
Q

Hereditary cause of AA: cafe au lait spots, VACTERL phenotype

A

Fanconi anemia

83
Q

Hereditary cause of AA: bilateral sensorineural deafness, agranulocytosis, SCID

Results from a pluripotential stem cell defect as both lymphoid and granulocytic progenitors are affected.

A

Reticular dysgenesis

84
Q

Results from mutations in the ATR gene, and marrow cells exhibit heightened sister chromatid exchange

A

Seckel syndrome

85
Q

TRUE OR FALSE

Inherited aplastic anemias can be treated by hematopoietic cell transplantation but, if successful, this step does not correct somatic abnormalities, only the hematopoietic and immunologic defect.

A

TRUE

Inherited aplastic anemias can be treated by hematopoietic cell transplantation but, if successful, this step does not correct somatic abnormalities, only the hematopoietic and immunologic defect.

WILLIAM'S HEMATOLOGY (109 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions